Uncovering potential biomarkers for chronic kidney disease of unknown etiology through a network-based bioinformatic

Aleeta Maria Jolly1, Sonu Benny2, Aneesh Thankappan Presanna2

  • 1Department of Pharmacology, Amrita Vishwa Vidyapeetham-Kochi Campus, Amrita School of Pharmacy, Kochi, Kerala, India.

Insights

Chronic kidney disease of unknown cause (CKDu) involves tubular injury. This study identified key genes like SPP1, TNF, and IL-6, crucial for CKDu initiation and progression, suggesting potential biomarkers.

Area of Science:

  • Nephrology
  • Bioinformatics
  • Molecular Biology

Background:

  • Chronic kidney disease of unknown cause (CKDu) is defined by a sustained decline in estimated glomerular filtration rate (eGFR) without identifiable risk factors.
  • Biopsy studies indicate that renal tubular injury plays a significant role in the pathogenesis of CKDu.

Purpose of the Study:

  • To employ a network-based bioinformatics approach to identify potential biomarkers and elucidate their roles in CKDu.
  • To pinpoint key genes and pathways implicated in the initiation and progression of renal tubular injury in CKDu.

Main Methods:

  • Conducted a comprehensive literature survey across PubMed, Scopus, and Science Direct, focusing on renal tubular injury markers.
  • Utilized network analysis with Cytoscape and enrichment analysis with Cluego on 43 identified genes associated with CKDu.
  • Analyzed topological properties and functional enrichment of selected genes to identify hub genes and biological pathways.

Main Results:

  • Identified 37 biomarkers and 43 corresponding genes from 40 research articles related to CKDu.
  • SPP1 emerged as the hub gene, with SPP1, TNF, CLU, CST3, CRP, TGFB1, and IL-6 ranking highest in network centrality.
  • Functional analysis indicated localization to collagen type IV trimers in renal tubules and monooxygenase activity for detoxification, with TLR signaling implicated in inflammation.

Conclusions:

  • The identified genes (SPP1, TNF, CLU, CST3, CRP, TGFB1, IL-6) are critically involved in the initiation and progression of CKDu.
  • These genes and associated pathways represent promising candidates for further investigation as diagnostic and prognostic biomarkers for CKDu.
  • Biological validation studies are necessary to confirm the biomarker potential of these identified genes in CKDu.

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
1.2K
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
645
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
315
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate01:25

Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate

The glomerular filtration rate (GFR) is a critical indicator of kidney health, reflecting how well the kidneys filter blood. Changes in GFR can signal potential kidney impairment, necessitating accurate measurement methods to monitor kidney function effectively.Various molecules can serve as markers for GFR measurement, with the ideal marker meeting several specific criteria. It must freely filter at the glomerulus, avoid reabsorption or secretion by the renal tubules, remain unmetabolized, not...
119
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
515